Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
US Department of Justice
McKesson
Daiichi Sankyo
Harvard Business School
QuintilesIMS
Fish and Richardson
Federal Trade Commission
Baxter

Generated: January 19, 2018

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

« Back to Dashboard

What are the generic sources for entacapone and what is the scope of entacapone patent protection?

Entacapone
is the generic ingredient in two branded drugs marketed by Orion Pharma, Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Sun Pharma Global, and Wockhardt Ltd, and is included in seven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Entacapone has forty-eight patent family members in thirty-seven countries.

There are nineteen drug master file entries for entacapone. Seventeen suppliers are listed for this compound.
Pharmacology for entacapone

US Patents and Regulatory Information for entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd ENTACAPONE entacapone TABLET;ORAL 207210-001 Jun 5, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ajanta Pharma Ltd ENTACAPONE entacapone TABLET;ORAL 205792-001 Aug 31, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global ENTACAPONE entacapone TABLET;ORAL 090690-001 Jul 16, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc ENTACAPONE entacapone TABLET;ORAL 202394-001 May 13, 2013 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Aurobindo Pharma Ltd ENTACAPONE entacapone TABLET;ORAL 203437-001 Jun 19, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt Ltd ENTACAPONE entacapone TABLET;ORAL 078941-001 Aug 16, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Subscribe ➤ Subscribe
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Subscribe ➤ Subscribe
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Subscribe ➤ Subscribe
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for entacapone

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Daiichi Sankyo
McKesson
Julphar
Citi
Colorcon
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot